Platelet activation in congenital heart diseases

Pediatrics International - Tập 39 Số 5 - Trang 566-569 - 1997
Nur Olgun1, Kamer Mutafoğlu, Gülersu İrken, Nurettin Ünal, Bülent Ündar, Nurullah Akkoç, A Akçoral, Faik Sarıalioğlu, N Cevik
1School of Medicine, Dokuz Eylül University, Izmir, Turkey

Tóm tắt

AbstractThe research presented here investigated platelet activation in cyanotic and acyanotic congenital heart diseases (CHD). Children with cyanotic CHD are prone to both thrombosis and hemorrhage. However, patients with acyanotic CHD may also have a mild bleeding disorder. The platelet activation in CHD was investigated in support of a hypothesis that platelet activation may play a role in the hemostatic abnormalities reported in these patients. Platelet activation was determined by using flow cytometry with anti‐CD62 monoclonal antibody (mAb), which has been shown to be a specific marker of platelet activation. Thirteen children with cyanotic CHD, 33 children with acyanotic CHD and 17 healthy children serving as controls were studied. Platelet activation was significantly higher in the cyanotic group and also in the acyanotic group compared with the healthy children (P = 0.0000 and P = 0.019, respectively). In the cyanotic group, platelet activation showed a direct correlation with arterial O2 saturation (SaO2) (P = 0.014). There was no correlation between platelet activation and erythrocyte related parameters in either group. Platelet activation occurs in CHD, particularly in patients with cyanotic CHD (even in patients with no evidence of clinical thrombosis) and it may play a role in the pathogenesis of thrombotic disorders seen in these patients.

Từ khóa


Tài liệu tham khảo

Phornphutkul C., 1973, Cerebrovascular accidents in infants and children with cyanotic congenital heart disease, Am. J. Cardiol., 22, 219

Ekert H., 1974, Preoperative and postoperative platelet function in cyanotic congenital heart disease, J. Thorac. Cardiovasc. Surg., 67, 184, 10.1016/S0022-5223(19)40534-5

Maurer HM, 1972, Impairment in platelet aggregation in congenital heart disease, Blood, 40, 207, 10.1182/blood.V40.2.207.207

10.1136/hrt.41.1.23

10.1016/S0022-3476(75)80073-4

Wu G., 1992, Detection of activated platelet using activation‐dependent monoclonal antibody SZ‐51 in clinical disorders, Nouv. Rev. Fr. Hematol., 34, 31

Gottl Nowak U., 1992, Gerinnungsphysiologische untersuchungen bei idiopathischen arteriellen Thrombosen, Monatsschr. Kinderheilled., 140, 183

10.1083/jcb.101.3.880

10.1097/00000542-199109000-00002

Abrams C., 1991, Immunologic detection of activated platelets in clinical disorders, Thromb. Haemost., 65, 467, 10.1055/s-0038-1648173

10.1161/01.CIR.88.6.2728

Rinder CS, 1994, Platelet‐leucocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass, J. Thorac. Cardiovasc. Surg., 107, 280, 10.1016/S0022-5223(94)70482-1

Rinder CS, 1992, Cardiopulmonary bypass induced leucocyte‐platelet adhesion, Blood, 79, 1202, 10.1182/blood.V79.5.1201.1201

Brandt CM, 1992, Platelet activation revealed by reduced serotonin content in various left ventricular hypertrophic states, Acta Cardiolog., 3, 271

Thông tin
Thông tin xuất bản

Pediatrics International

Tập 39 Số 5

566-569

Thông tin tác giả